International Clinical Trial: A Prospective, Single-Arm, Single-Center, Exploratory Clinical Trial of Vibecotamab in Combination with Cisplatin as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Nasopharyngeal Skull Base

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132338) titled 'A Prospective, Single-Arm, Single-Center, Exploratory Clinical Trial of Vibecotamab in Combination with Cisplatin as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Nasopharyngeal Skull Base' on Sept. 12.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Eye & ENT hospital of Fudan University

Condition: Locally advanced sinonasal skull base squamous cell carcinoma

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-29

Target Sample Size: Intervention group:20;

Countries of Recruitment: China

To know more, visit https://www.chic...